2003
DOI: 10.1016/s0272-6386(03)00361-5
|View full text |Cite
|
Sign up to set email alerts
|

Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
195
3
5

Year Published

2006
2006
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 274 publications
(211 citation statements)
references
References 16 publications
8
195
3
5
Order By: Relevance
“…Both diabetes and nutritional status are linked to PCS and MCS scores (23). Importantly, there were no diabetic subjects in this COHORT, and all were relatively healthy and demonstrated good nutritional status based on their estimated dietary protein intake (data not shown).…”
Section: Discussionmentioning
confidence: 93%
“…Both diabetes and nutritional status are linked to PCS and MCS scores (23). Importantly, there were no diabetic subjects in this COHORT, and all were relatively healthy and demonstrated good nutritional status based on their estimated dietary protein intake (data not shown).…”
Section: Discussionmentioning
confidence: 93%
“…The SF-36 and KDQOL have been used extensively in the dialysis population. [1][2][3][4][5][6] We scored the instrument according to the recommendations of its developers, i.e., using the RAND method of scoring. 20,21 …”
Section: Health-related Quality Of Lifementioning
confidence: 99%
“…[1][2][3][4][5][6] Thus, there has been considerable interest in elucidating the determinants of poor self-reported physical functioning. Demographic factors such as age, race, and sex are associated with differences in self-reported physical functioning in this population, [2][3][4]7 but these are not potential targets for intervention.…”
Section: Introductionmentioning
confidence: 99%
“…Because HRQOL is a consistent predictor of mortality in ESRD (8,(11)(12)(13)(14), there is interest in measuring HRQOL in both clinical trials and everyday clinical practice. This acknowledgment that the burden of ESRD extends beyond its impact on traditional biologic measures is reflected in initiatives from the National Kidney Foundation to support efforts aimed at improving HRQOL in patients with ESRD (5); however, many clinicians are not well versed in the interpretation of HRQOL, and HRQOL may fail to resonate with clinicians in the same way as traditional biomarkers such as dialysis adequacy indices, mineral metabolism markers, or anemia markers, among others.…”
mentioning
confidence: 99%